Renal cell carcinoma associated with Xp11. 2 translocation/transcription factor E3 gene fusion: A case report and literature review
D Yang, W Tang, M Liu, Z Xie, F Shi… - Oncology …, 2023 - spandidos-publications.com
Renal cell carcinoma (RCC) associated with Xp11. 2 translocation/transcription factor E3
(TFE3) gene fusion is a rare subtype of RCC. A 31-year-old male patient was admitted to …
(TFE3) gene fusion is a rare subtype of RCC. A 31-year-old male patient was admitted to …
[HTML][HTML] Case Reports of TFE3-Rearranged Renal Cell Carcinoma: FDG-PET Uptake Might Help Diagnosis
S Murakami, K Nagawa, T Inui… - Journal of Kidney …, 2023 - ncbi.nlm.nih.gov
Translocation and transcription factor E3 (TFE3)-rearranged renal cell carcinoma (RCC) is a
rare subtype of RCCs characterised by the fusion of the TFE3 transcription factor genes on …
rare subtype of RCCs characterised by the fusion of the TFE3 transcription factor genes on …
Clear cell and non-clear cell renal cell carcinoma in young adults: clinicopathological features, survival outcomes and prognostic factors
Z Xue, S Tang, J Ou, Y Fang, M Qiu, K Hong… - World Journal of …, 2024 - Springer
Objectives Renal cell carcinoma (RCC) is infrequent among young adults. Few studies
reported the outcome of RCC in young adults by pathological subtypes. The purpose of this …
reported the outcome of RCC in young adults by pathological subtypes. The purpose of this …
Diagnostic performance and prognostic value of preoperative 18F-FDG PET/CT in renal cell carcinoma patients with venous tumor thrombus
S Chen, Y Zhao, Q Tang, C Wu, A Wang, L Ma… - Cancer Imaging, 2022 - Springer
Background To observe the diagnostic efficacy of preoperative fluorine-18
fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography …
fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography …
The clinicopathological characteristics and prognosis of 55 patients with TFE3-rearranged renal cell carcinomas
YM Bai, L Yang, Y Yang, XX Wang, MD Zheng… - Clinical Genitourinary …, 2024 - Elsevier
Objective To explore the clinicopathological features and prognosis of TFE3-rearranged
renal cell carcinomas (TFE3-rRCC). Methods In this retrospective observational study, the …
renal cell carcinomas (TFE3-rRCC). Methods In this retrospective observational study, the …
Four years of natural progressive course: A rare case report of juvenile Xp11.2 translocations renal cell carcinoma with TFE3 gene fusion
L Hu, L Li, A Li, J Tong - Open Medicine, 2024 - degruyter.com
Background Renal cell carcinoma (RCC) with TFE3 gene fusion caused by Xp11. 2
translocations is a rare RCC subtype. This tumor is typically seen in children, comprising 20 …
translocations is a rare RCC subtype. This tumor is typically seen in children, comprising 20 …
[HTML][HTML] CASE REPORT Case Reports of TFE3-Rearranged Renal Cell Carcinoma: FDG-PET Uptake Might Help Diagnosis
S Murakami, K Nagawa, T Inui, A Yamamoto, M Suzuki… - jkcvhl.com
Translocation and transcription factor E3 (TFE3)-rearranged renal cell carcinoma (RCC) is a
rare subtype of RCCs characterised by the fusion of the TFE3 transcription factor genes on …
rare subtype of RCCs characterised by the fusion of the TFE3 transcription factor genes on …